TFS
TXMD icon

TrustCore Financial Services’s TherapeuticsMD TXMD Stock Holding History

TrustCore Financial Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19
Closed -$1K – 1157
2021
Q2 		$1K Sell
19
-8
-30% -$485 ﹤0.01% 1037
2021
Q1 		$2K Hold
27
– – ﹤0.01% 870
2020
Q4 		$2K Hold
27
– – ﹤0.01% 854
2020
Q3 		$2K Hold
27
– – ﹤0.01% 781
2020
Q2 		$2K Hold
27
– – ﹤0.01% 815
2020
Q1 		$1K Buy
27
+1
+4% +$99 ﹤0.01% 849
2019
Q4 		$3K Buy
+26
New +$3.74K ﹤0.01% 803

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TrustCore Financial Services's TXMD Position: Q3 2021 in Review

TrustCore Financial Services sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 19 shares — an estimated $1K sold.

TrustCore Financial Services first reported a position in TXMD in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q4 2019. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • TrustCore Financial Services reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • TrustCore Financial Services sold 19 TherapeuticsMD shares in Q3 2021, an estimated $1K.
  • TrustCore Financial Services first reported a position in TherapeuticsMD in Q4 2019 and held it in 7 quarters.
  • TrustCore Financial Services's TherapeuticsMD position peaked at $3K in Q4 2019.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on TrustCore Financial Services's 13F filing for Q3 2021, filed 8 Nov 2021.